Akela total consolidated revenues increase to $7.

$0.17 million, for the same period in 2010 2010. The Company had a cash balance of $0.of June 30 21 as, in comparison with $0.14 million by March 31, 2011.. Akela total consolidated revenues increase to $7.june 30 3M for six months ended, 2011 Akela Pharma, Inc. , and PharmaForm, a leading specialty contract company in the area of pharmaceutical dosage form manufacturing and development, announced its financial outcomes for the three and six months and year finished June 30 today, 2011. June 30 Total consolidated revenues for the 90 days ended, 2011 were $3.1 million, including $2.4 million of contract companies, in comparison with $3.1 million, including $2.4 million of contract companies, for the same period during the prior year.3 million as compared to $5.7 million for the same period this year 2010.The CE Tag demonstrates that the company is definitely in compliance with the regulatory requirements of Medical Products Directive and allows the company to market the device in any EU member country and in other selected international marketplaces, said Forrest Rudnick, ABS Vice President Quality Assurance. The certification of a quality management system, designed for the produce of products included in the new Strategy EC Directives, is essential for ABS to export items to the global market.